Cargando…
Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
BACKGROUND: Early detection of subclinical cardiotoxicity of immune checkpoint inhibitor (ICI) therapy can be challenging. OBJECTIVE: To evaluate subclinical cardiac dysfunction using two-dimensional speckle tracking imaging (2D-STI) and three-dimensional echocardiography in Chinese patients. METHOD...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812579/ https://www.ncbi.nlm.nih.gov/pubmed/36620612 http://dx.doi.org/10.3389/fcvm.2022.1087287 |
_version_ | 1784863759778447360 |
---|---|
author | Xu, Aiqing Yuan, Ming Zhan, Xiaoping Zhao, Gangjian Mu, Guanyu Wang, Tingting Hu, Hailong Fu, Huaying |
author_facet | Xu, Aiqing Yuan, Ming Zhan, Xiaoping Zhao, Gangjian Mu, Guanyu Wang, Tingting Hu, Hailong Fu, Huaying |
author_sort | Xu, Aiqing |
collection | PubMed |
description | BACKGROUND: Early detection of subclinical cardiotoxicity of immune checkpoint inhibitor (ICI) therapy can be challenging. OBJECTIVE: To evaluate subclinical cardiac dysfunction using two-dimensional speckle tracking imaging (2D-STI) and three-dimensional echocardiography in Chinese patients. METHODS: Fifty-five consecutive patients with malignant tumors treated by immunotherapy were included. They were examined by echocardiography before immunotherapy and after immunotherapy. Left ventricular ejection fraction (LVEF) was calculated in three-dimensional imaging. Moreover, left ventricular global longitudinal peak systolic strain (LVGLS), left ventricular global circumferential peak systolic strain (LVGCS), right ventricular global longitudinal systolic strain (RVGLS), right ventricular free wall longitudinal peak systolic strain (RVFWLS), and tricuspid annular plane systolic excursion (TAPSE) were evaluated. Clinical and laboratory parameters were recorded. Cardiac toxicity events were defined as the presence of heart failure symptoms, LVEF reduction, and increase in troponin. Subclinical cardiac toxicity was defined as cardiac dysfunction associated with ICI treatment, with absent or delayed ICI-associated cardiotoxicity clinical symptoms. RESULTS: Compared with baseline, the LVGLS, TAPSE, and RVGLS significantly deteriorated after ICI treatment [(–18.63 ± 2.53)% vs. (–17.35 ± 2.58)%, P = 0.000; 18.29 ± 6.23 vs. 14.57 ± 3.81, P = 0.0001; and (–18.45 ± 4.65)% vs. (–14.98 ± 3.85)%, P = 0.0001, respectively]. LVGLS (–17.35 ± 2.58, P = 0.000), TAPSE (14.57 ± 3.81, P = 0.0001), and RVGLS [(–14.98 ± 3.85)%, P = 0.0001] were decreased after ICI immunotherapy. Kaplan-Meier curve analysis showed that LVGLS was more sensitive than the cardiac toxicity events to assess ICI-related subclinical cardiac dysfunction (log-rank P = 0.205). The ROC curve showed that the cutoff value of ΔLVGLS was -13%. CONCLUSION: Subclinical cardiac dysfunction can be detected using two-dimensional speckle-tracking imaging. LVGLS, RVGLS, and TAPSE are more sensitive indices for detection. CLINICAL TRIAL REGISTRATION: [https://www.chictr.org.cn/showprojen.aspx?proj=27498], identifier [ChiCTR1800016216]. |
format | Online Article Text |
id | pubmed-9812579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98125792023-01-05 Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography Xu, Aiqing Yuan, Ming Zhan, Xiaoping Zhao, Gangjian Mu, Guanyu Wang, Tingting Hu, Hailong Fu, Huaying Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Early detection of subclinical cardiotoxicity of immune checkpoint inhibitor (ICI) therapy can be challenging. OBJECTIVE: To evaluate subclinical cardiac dysfunction using two-dimensional speckle tracking imaging (2D-STI) and three-dimensional echocardiography in Chinese patients. METHODS: Fifty-five consecutive patients with malignant tumors treated by immunotherapy were included. They were examined by echocardiography before immunotherapy and after immunotherapy. Left ventricular ejection fraction (LVEF) was calculated in three-dimensional imaging. Moreover, left ventricular global longitudinal peak systolic strain (LVGLS), left ventricular global circumferential peak systolic strain (LVGCS), right ventricular global longitudinal systolic strain (RVGLS), right ventricular free wall longitudinal peak systolic strain (RVFWLS), and tricuspid annular plane systolic excursion (TAPSE) were evaluated. Clinical and laboratory parameters were recorded. Cardiac toxicity events were defined as the presence of heart failure symptoms, LVEF reduction, and increase in troponin. Subclinical cardiac toxicity was defined as cardiac dysfunction associated with ICI treatment, with absent or delayed ICI-associated cardiotoxicity clinical symptoms. RESULTS: Compared with baseline, the LVGLS, TAPSE, and RVGLS significantly deteriorated after ICI treatment [(–18.63 ± 2.53)% vs. (–17.35 ± 2.58)%, P = 0.000; 18.29 ± 6.23 vs. 14.57 ± 3.81, P = 0.0001; and (–18.45 ± 4.65)% vs. (–14.98 ± 3.85)%, P = 0.0001, respectively]. LVGLS (–17.35 ± 2.58, P = 0.000), TAPSE (14.57 ± 3.81, P = 0.0001), and RVGLS [(–14.98 ± 3.85)%, P = 0.0001] were decreased after ICI immunotherapy. Kaplan-Meier curve analysis showed that LVGLS was more sensitive than the cardiac toxicity events to assess ICI-related subclinical cardiac dysfunction (log-rank P = 0.205). The ROC curve showed that the cutoff value of ΔLVGLS was -13%. CONCLUSION: Subclinical cardiac dysfunction can be detected using two-dimensional speckle-tracking imaging. LVGLS, RVGLS, and TAPSE are more sensitive indices for detection. CLINICAL TRIAL REGISTRATION: [https://www.chictr.org.cn/showprojen.aspx?proj=27498], identifier [ChiCTR1800016216]. Frontiers Media S.A. 2022-12-21 /pmc/articles/PMC9812579/ /pubmed/36620612 http://dx.doi.org/10.3389/fcvm.2022.1087287 Text en Copyright © 2022 Xu, Yuan, Zhan, Zhao, Mu, Wang, Hu and Fu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Xu, Aiqing Yuan, Ming Zhan, Xiaoping Zhao, Gangjian Mu, Guanyu Wang, Tingting Hu, Hailong Fu, Huaying Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography |
title | Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography |
title_full | Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography |
title_fullStr | Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography |
title_full_unstemmed | Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography |
title_short | Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography |
title_sort | early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: a pilot study by using speckle tracking imaging and three-dimensional echocardiography |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812579/ https://www.ncbi.nlm.nih.gov/pubmed/36620612 http://dx.doi.org/10.3389/fcvm.2022.1087287 |
work_keys_str_mv | AT xuaiqing earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography AT yuanming earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography AT zhanxiaoping earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography AT zhaogangjian earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography AT muguanyu earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography AT wangtingting earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography AT huhailong earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography AT fuhuaying earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography |